Comparison between Dr Lalchandani Labs IPO and Indo US Bio-Tech IPO.
IPO Details
Dr Lalchandani Labs IPO is a SME Fixed Price IPO proposed to list at BSE SME while Indo US Bio-Tech IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of Dr Lalchandani Labs IPO is up to ₹3.98 Cr whereas the issue size of the Indo US Bio-Tech IPO is up to ₹6.92 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of Indo US Bio-Tech IPO is ₹51.00 per share.
IPO Timetable
Dr Lalchandani Labs IPO opens on Apr 25, 2018, while Indo US Bio-Tech IPO opens on Apr 30, 2018. The closing date of Dr Lalchandani Labs IPO and Indo US Bio-Tech IPO is Apr 27, 2018, and May 03, 2018, respectively.
Financials & KPIs
Dr Lalchandani Labs IPO P/E ratio is , as compared to Indo US Bio-Tech IPO P/E ratio of .
Shares Offered
In the Dr Lalchandani Labs IPO Retail Individual Investors (RII) are offered 6,64,000 shares while in Indo US Bio-Tech IPO retail investors are offered 6,64,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Dr Lalchandani Labs IPO and 0 shares in Indo US Bio-Tech IPO.
| | Dr Lalchandani Labs IPO | Indo US Bio-Tech IPO |
|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 72,000 shares | 74,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 6,64,000 shares | 6,78,000 shares |
| RII | 6,64,000 shares | 6,78,000 shares |
| Employee | 0 shares | 0 shares |
| Total | 13,28,000 shares | 13,56,000 shares |
Bids Received (Subscription)
Dr Lalchandani Labs IPO subscribed 4.63x in total, whereas Indo US Bio-Tech IPO subscribed 19.69x.
